These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 3786833)
1. Pharmacological profile of a new peptidic gastrin antagonist. Lavezzo A; Bali JP; Magous R; Lignon MF; Nisato D; Laur J; Castro B; Martinez J Regul Pept; 1986 Sep; 15(2):111-9. PubMed ID: 3786833 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of gastrin- and histamine-stimulated gastric acid secretion by gastrin and cholecystokinin antagonists in the rat. Hirst BH; Elliott KJ; Ryder H; Szelke M Aliment Pharmacol Ther; 1991 Feb; 5(1):31-9. PubMed ID: 1932479 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological analysis of the CCKB/gastrin receptors mediating pentagastrin-stimulated gastric acid secretion in the isolated stomach of the immature rat. Hills DM; Gerskowitch VP; Roberts SP; Welsh NJ; Shankley NP; Black JW Br J Pharmacol; 1996 Dec; 119(7):1401-10. PubMed ID: 8968549 [TBL] [Abstract][Full Text] [Related]
4. Pharmacology of JB-9315, a new selective histamine H2-receptor antagonist. Palacios B; Montero MJ; Sevilla MA; San Román L Gen Pharmacol; 1998 Feb; 30(2):181-9. PubMed ID: 9502172 [TBL] [Abstract][Full Text] [Related]
5. Characterization of antigastrin activity in vivo of CR 2194, a new R-4-benzamido-5-oxo-pentanoic acid derivative. Revel L; Ferrari F; Makovec F; Rovati LC; Impicciatore M Eur J Pharmacol; 1992 Jun; 216(2):217-24. PubMed ID: 1397008 [TBL] [Abstract][Full Text] [Related]
6. Role of N- and C-terminal substituents on the CCK-B agonist-antagonist pharmacological profile of Boc-Trp-Phg-Asp-Nal-NH2 derivatives. Weng JH; Blommaert AG; Moizo L; Bado A; Ducos B; Böhme A; Garbay C; Roques BP Bioorg Med Chem; 1996 Apr; 4(4):563-73. PubMed ID: 8735845 [TBL] [Abstract][Full Text] [Related]
7. YM022, a highly potent and selective CCKB antagonist inhibiting gastric acid secretion in the rat, the cat and isolated rabbit glands. Attoub S; Moizo L; Laigneau JP; Alchepo B; Lewin MJ; Bado A Fundam Clin Pharmacol; 1998; 12(3):256-62. PubMed ID: 9646057 [TBL] [Abstract][Full Text] [Related]
8. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist. Makovec F; Revel L; Letari O; Mennuni L; Impicciatore M Eur J Pharmacol; 1999 Mar; 369(1):81-90. PubMed ID: 10204685 [TBL] [Abstract][Full Text] [Related]
9. Novel C-terminal gastrin antagonists. Synthesis and biological activity. Yasui A; Douglas AJ; Walker B; Magee DF; Murphy RF Int J Pept Protein Res; 1990 Apr; 35(4):301-5. PubMed ID: 2345051 [TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of pentagastrin- and cholecystokinin-stimulated exocrine secretion by proglumide. Loewe CJ; Grider JR; Gardiner J; Vlahcevic ZR Gastroenterology; 1985 Oct; 89(4):746-51. PubMed ID: 2863192 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of pseudo-peptide analogues of the C-terminal tetrapeptide of gastrin and evaluation of their biological activity on acid secretion. Rodriguez M; Bali JP; Magous R; Castro B; Martinez J Int J Pept Protein Res; 1986 Mar; 27(3):293-9. PubMed ID: 3011690 [TBL] [Abstract][Full Text] [Related]
12. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat. Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of gastrin antagonists, analogues of the C-terminal tetrapeptide of gastrin, by introduction of a beta-homo residue. Rodriguez M; Fulcrand P; Laur J; Aumelas A; Bali JP; Martinez J J Med Chem; 1989 Mar; 32(3):522-8. PubMed ID: 2918498 [TBL] [Abstract][Full Text] [Related]
15. Effects of YF476, a potent and selective gastrin/cholecystokinin-B receptor antagonist, on gastric acid secretion in beagle dogs with gastric fistula. Takemoto Y; Yuki H; Nishida A; Ito H; Kobayashi-Uchida A; Takinami Y; Akuzawa S; Ohta M; Satoh M; Semple G; Miyata K Arzneimittelforschung; 1998 Apr; 48(4):403-7. PubMed ID: 9608884 [TBL] [Abstract][Full Text] [Related]
16. Functional comparisons of gastrin/cholecystokinin receptors in isolated preparations of gastric mucosa and ileum. Patel M; Spraggs CF Br J Pharmacol; 1992 Jun; 106(2):275-82. PubMed ID: 1393262 [TBL] [Abstract][Full Text] [Related]
17. Some in vitro and in vivo actions of the new histamine H2-receptor antagonist, ranitidine. Daly MJ; Humphray JM; Stables R Br J Pharmacol; 1981 Jan; 72(1):49-54. PubMed ID: 6112034 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological properties of ureido-acetamides, new potent and selective non-peptide CCKB/gastrin receptor antagonists. Bertrand P; Böhme GA; Durieux C; Guyon C; Capet M; Jeantaud B; Boudeau P; Ducos B; Pendley CE; Martin GE Eur J Pharmacol; 1994 Sep; 262(3):233-45. PubMed ID: 7813588 [TBL] [Abstract][Full Text] [Related]
19. Paradoxical effects of gastrin releasing peptide on gastrin release and gastric secretion in the rat. Takagi A; Moriga M; Narusawa H; Uchino H; Aono M Gastroenterol Jpn; 1986 Dec; 21(6):573-8. PubMed ID: 3106128 [TBL] [Abstract][Full Text] [Related]
20. Gastric secretion and gastrin under progressive doses of somatostatin-14 and -28 administered intraperitoneally to the rat. Seefried G; Schmidtler J; Schwille PO Peptides; 1988; 9(2):249-55. PubMed ID: 2897678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]